Methods and compositions for the treatment of degenerate bone
AssigneeAnika Therapeutics, Inc.
InventorsEdward S. Ahn, Chia-En Lin, Colin D. White
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods and compositions for the treatment of degenerate bone in a patient. In some embodiments, the methods and compositions disclosed herein are useful in the treatment, prevention, or in delaying the progression of a bone disease linked to bone degeneration, such as osteoarthritis (“OA”), rheumatoid arthritis, and avascular necrosis.
Claims43
An injectable biomaterial comprising:
- (a) a solid component;
- and
- (b) a liquid component comprising a carbohydrate;
- wherein the injectable biomaterial sets and cures to form an apatitic crystal structure after mixing of the solid component and the liquid component;
- wherein the ratio of solid component to liquid component is about 3 to about 1 by mass;
- and
- wherein the fully set and cured injectable biomaterial comprises a median pore diameter of less than about 1 μm.
3-5. (canceled)
(canceled)
9-20. (canceled)
23-26. (canceled)
28-56. (canceled)
59-110. (canceled)
112-117. (canceled)
119-178. (canceled)
(canceled)
184-209. (canceled)
211-222. (canceled)
224-225. (canceled)
228-248. (canceled)
250-255. (canceled)
(canceled)
260-267. (canceled)
269-279. (canceled)
281-283. (canceled)
Dependencies are inferred from the claim text.